同和药业原料药美阿沙坦钾通过药品GMP符合性检查

Core Viewpoint - Tonghua Dongbao Pharmaceutical announced that its raw material drug, Azilsartan potassium, has passed the GMP compliance inspection by the Jiangxi Provincial Drug Administration, indicating its suitability for treating adult primary hypertension [1] Group 1 - The company received a notification regarding the GMP compliance inspection results for Azilsartan potassium [1] - Azilsartan potassium is indicated for the treatment of adult primary hypertension [1]